Newbridge Financial Services Group’s Royalty Pharma RPRX Stock Holding History

Newbridge Financial Services Group’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Hold	0	–	–	–	1267
2025 Q4	–	Hold	0	–	–	–	1433
2023 Q4	–	Sell	-50	Closed	-$1.36K	–	1303
2023 Q3	$1.36K	Hold	50	–	–	﹤0.01%	1128
2023 Q2	$1.54K	Hold	50	–	–	﹤0.01%	1168
2023 Q1	$1.8K	Hold	50	–	–	﹤0.01%	1210
2022 Q4	$1.98K	Hold	50	–	–	﹤0.01%	1216
2022 Q3	$2K	Hold	50	–	–	﹤0.01%	1229
2022 Q2	$2K	Hold	50	–	–	﹤0.01%	1214
2022 Q1	$2K	Hold	50	–	–	﹤0.01%	1319
2021 Q4	$2K	Hold	50	–	–	﹤0.01%	1267
2021 Q3	$2K	Hold	50	–	–	﹤0.01%	1197
2021 Q2	$2K	Hold	50	–	–	﹤0.01%	1294
2021 Q1	$2K	Buy	+50	New	+$2.37K	﹤0.01%	1191

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return